Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Healing II: Complications

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...

Biological Effects of Radiation

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Hemodialysis II: Procedure and Complications

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Definitive chemoradiotherapy in elderly patients with esophageal cancer: Safety and outcome.

Precision radiation oncology·2025

Same author

Current availability of radiotherapy devices in Peru and artificial intelligence-based analysis for constructing a nationwide implementation plan.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025

Same author

Trends in the treatment of human papillomavirus-associated oropharyngeal carcinoma in Slovakia.

Neoplasma·2024

Same author

Leveling Up the Access to Radiation Therapy in Latin America: Economic Analysis of Investment, Equity, and Inclusion Opportunities Up to 2030.

International journal of radiation oncology, biology, physics·2022

Same author

Human Papillomavirus-Related Non-Metastatic Oropharyngeal Carcinoma: Current Local Treatment Options and Future Perspectives.

Cancers·2022

Same author

Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer-How to Identify Patients Which Can Benefit from It?

Current oncology (Toronto, Ont.)·2022

Search research articles

Related Experiment Videos

Normal tissue complications after radiation therapy.

Jolyon H Hendry¹, Branislav Jeremić, Eduardo H Zubizarreta

¹International Atomic Energy Agency, Division of Human Health, Applied Radiobiology and Radiotherapy Section, Vienna, Austria. j.hendry@iaea.org

Revista Panamericana De Salud Publica = Pan American Journal of Public Health

|January 4, 2007

Summary

This study explores normal tissue reactions in radiation therapy, detailing biological mechanisms, dose-response relationships, and treatment modifications. It emphasizes advancing clinical radiobiology and improving cancer care globally.

Related Experiment Videos

Area of Science:

Radiobiology
Radiation Oncology
Clinical Radiobiology

Background:

Understanding normal tissue responses to radiation therapy is crucial for optimizing cancer treatment.
Biological mechanisms underlying latency periods and tissue complications require further elucidation.
Variations in treatment protocols, particularly in developing countries, necessitate the development of resource-sparing strategies.

Purpose of the Study:

To describe the biological mechanisms of normal tissue reactions following radiation therapy.
To explore factors influencing tissue complications, including dose, volume, fractionation, and combined treatments.
To discuss advancements in clinical radiobiology and potential treatment modifications.

Main Methods:

Review of preclinical and clinical data on radiation therapy effects.
Analysis of dose-response relationships, volume effects, and fractionation schedules.
Examination of combined chemotherapy and radiotherapy responses and biological response modifiers.

Main Results:

Established understanding of biological mechanisms driving normal tissue reactions and latency periods.
Identified key factors influencing early and late tissue reactions.
Highlighted the impact of dose fractionation, dose rate, and combined treatments on outcomes.
Demonstrated the potential of biological response modifiers and response prediction in treatment modification.

Conclusions:

Advances in radiobiology have led to new physical and biological strategies in radiotherapy.
Efficacious, resource-sparing protocols are essential for cancer treatment in developing countries.
A unified scoring system for adverse effects and actuarial reporting of late toxicity are recommended standards.